Skip to main content
Fig. 11 | BMC Cancer

Fig. 11

From: Identification and characterization of stromal-like cells with CD207+/low CD1a+/low phenotype derived from histiocytic lesions – a perspective in vitro model for drug testing

Fig. 11

Comparison of IC50 values for vemurafenib (a) and trametinib (b) using a model of sl-pHCs. IC50 values are presented as columns with bars representing mean value ± SD. Statistical differences were indicated: ** p-value < 0.01, *** p-value < 0.001, and ****p-value < 0.0001, while the “ns” symbol refers to non-significant differences

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us